Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of SGLT2 Inhibition on Adipose Tissue Inflammation and Endothelial Function Pilot

NCT04907214 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT04907214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04907214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of SGLT2 Inhibition on Adipose Tissue Inflammation and Endothelial Function Pilot
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
July 29, 2021
Completion date
December 8, 2023
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, pre-diabetes